絞り込み

16599

広告

「"ageno w"[Author]」の検索結果

455件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Treatment of venous thromboembolism with tinzaparin in oncological patients.

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment.

Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation).

XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.

Position paper on laboratory testing for patients with haemophilia. A consensus document from SISET, AICE, SIBioC and SIPMeL.

Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly.

The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.

Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs.

Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry.

Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes.

Breadth of complications of long-term oral anticoagulant care.

XXV Congresso Nazionale della Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET).

Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis.

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply.

Ultrasound Elastography is useful to distinguish Acute and Chronic Deep Vein Thrombosis.

Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study.

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.

Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
Sort by
※並べ替えは表示に時間がかかります